Protein prenylation inhibitors under study at Pierre Fabre for use in cancer, etc. March 11, 1999 No Comments
Bristol-Myers Squibb completes U.S. filing for Orzel, the first oral treatment for colon cancer March 11, 1999 No Comments
Novogen's phenolic hormone-derived anticancer drug shows potent activity against prostate cancer March 10, 1999 No Comments
AN-207, a targeted cytotoxic compound with potential in treating prostate cancer March 9, 1999 No Comments
Licensing opportunity from Yeda: vitamin D3 analogue with multiple potential indications March 9, 1999 No Comments
RSS